Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RYZB | DNLI | ALMS | ||
| Company | Rayzebio Inc | Denali Therapeutics Inc | Alumis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 62.49 | 23.23 | 28.24 | ||
| High | 62.50 | 23.57 | 28.60 | ||
| Low | 62.48 | 22.82 | 27.69 | ||
| Latest | 62.49 | 23.42 | 28.30 | ||
| Change | +0.01 | -0.22 | -0.51 | ||
| % Change | +0.02% | -0.93% | -1.77% | ||
| Volume | 282,700 | 1,113,000 | 649,900 | ||
| 20-Day Average Volume | 318,060 | 2,002,895 | 1,732,560 | ||
| Previous Close | 62.48 | 23.64 | 28.81 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 62.28 | 24.87 | 28.00 | ||
| 20-Day Raw Stochastic | 95.83% | 26.65% | 56.30% | ||
| 20-Day Relative Strength | 86.10 | 50.51 | 55.77 | ||
| Weighted Alpha | N/A | +67.89 | +153.97 | ||
| Today's Opinion | N/A | 80% Buy | 88% Buy | ||
| Previous Opinion | N/A | 80% Buy | 88% Buy | ||
| Last Month's Opinion | N/A | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 02/15/24 | +3.04% since 07/16/26 | +3.93% since 07/16/26 | ||
| Low | 62.42 on 02/16/24 | 22.52 on 07/21/26 | 26.58 on 07/17/26 | ||
| High | 62.51 on 02/22/24 | 24.05 on 07/22/26 | 30.11 on 07/21/26 | ||
| 1-Month | |||||
| %Chg | +0.87% since 01/23/24 | -5.45% since 06/23/26 | +15.46% since 06/23/26 | ||
| Low | 61.86 on 01/24/24 | 22.01 on 07/15/26 | 24.05 on 06/24/26 | ||
| High | 62.51 on 02/22/24 | 27.30 on 07/09/26 | 31.35 on 07/08/26 | ||
| 3-Month | |||||
| %Chg | +167.05% since 11/22/23 | +20.41% since 04/23/26 | +8.89% since 04/23/26 | ||
| Low | 22.14 on 11/27/23 | 17.71 on 05/19/26 | 18.36 on 06/09/26 | ||
| High | 62.51 on 02/22/24 | 27.30 on 07/09/26 | 31.35 on 07/08/26 | ||
| 6-Month | |||||
| %Chg | N/A since 09/15/23 | +15.65% since 01/23/26 | +15.42% since 01/23/26 | ||
| Low | 17.95 on 09/26/23 | 17.71 on 05/19/26 | 18.36 on 06/09/26 | ||
| High | 62.51 on 02/22/24 | 27.30 on 07/09/26 | 31.35 on 07/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,744,400 | 3,751,905 | 3,673,044 | ||
| Shares Outstanding, K | 59,920 | 158,710 | 127,492 | ||
| Annual Sales | 0 | 0 | 24,050,000 | ||
| Annual Net Income | -68,600,000 | -512,540,000 | -243,330,000 | ||
| Last Quarter Sales | 0 | 0 | 1,740,000 | ||
| Last Quarter Net Income | -18,190,000 | -128,450,000 | -93,050,000 | ||
| 60-Month Beta | N/A | 0.96 | -0.73 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 11/13/23 | -0.69 on 05/07/26 | -0.74 on 05/14/26 | ||
| Earnings Date | 03/04/24 | 08/10/26 | 08/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||